119 related articles for article (PubMed ID: 32157605)
21. Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer.
Liang B; Wang S; Zhu XG; Yu YX; Cui ZR; Yu YZ
World J Gastroenterol; 2005 Feb; 11(5):623-8. PubMed ID: 15655810
[TBL] [Abstract][Full Text] [Related]
22. [Clinicopathologic features and prognostic analyses of Borrmann type IV gastric cancer].
Ma JP; Chen JH; Cai SR; Chen CQ; Yang DJ; Wu H; He YL; Zhan WH
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(36):2534-7. PubMed ID: 23158792
[TBL] [Abstract][Full Text] [Related]
23. Borrmann Type 1 Cancer is Associated with a High Recurrence Rate in Locally Advanced Gastric Cancer.
Kim JH; Lee HH; Seo HS; Jung YJ; Park CH
Ann Surg Oncol; 2018 Jul; 25(7):2044-2052. PubMed ID: 29752601
[TBL] [Abstract][Full Text] [Related]
24. [Metastasis rates of lymph nodes and distribution in advanced gastric cancer and its clinical significance].
Nzengue JC; Zhan WH; Wang JP; Dong WG; Lan P; He YL; Chen ZX; Cai SR
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):506-9. PubMed ID: 17143796
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact and implications of extracapsular lymph node spread in Borrmann type IV gastric cancer.
Dong RZ; Guo JM; Zhang ZW; Zhou YM; Su Y
Oncotarget; 2017 Nov; 8(57):97593-97601. PubMed ID: 29228635
[TBL] [Abstract][Full Text] [Related]
26. Macroscopic appearance and biological character of gastric cancer invading the muscularis propria.
Ichiyoshi Y; Tomoda M; Tomisaki S; Oda S; Ohno S; Maehara Y; Sugimachi K
Hepatogastroenterology; 1996; 43(9):553-9. PubMed ID: 8799394
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses.
Yokota T; Kunii Y; Saito T; Teshima S; Narushima Y; Yamada Y; Iwamoto K; Kagami M; Takahashi M; Kikuchi S; Yamauchi H
Ups J Med Sci; 2000; 105(3):227-34. PubMed ID: 11261608
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of Borrmann type combined with vessel invasion status in advanced gastric cancer.
Zhai Z; Zhu ZY; Zhang Y; Yin X; Han BL; Gao JL; Lou SH; Fang TY; Wang YM; Li CF; Yu XF; Ma Y; Xue YW
World J Gastrointest Oncol; 2020 Sep; 12(9):992-1004. PubMed ID: 33005293
[TBL] [Abstract][Full Text] [Related]
29. Impact of AADAC gene expression on prognosis in patients with Borrmann type III advanced gastric cancer.
Wang Y; Fang T; Wang Y; Yin X; Zhang L; Zhang X; Zhang D; Zhang Y; Wang X; Wang H; Xue Y
BMC Cancer; 2022 Jun; 22(1):635. PubMed ID: 35681154
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological analysis of Borrmann type IV gastric cancer.
Yook JH; Oh ST; Kim BS
Cancer Res Treat; 2005 Apr; 37(2):87-91. PubMed ID: 19956485
[TBL] [Abstract][Full Text] [Related]
31. PN3b as an independent risk factor for poor prognosis and peritoneal recurrence in Borrmann type IV gastric cancer: A retrospective cohort study.
Chen Y; Chen Y; Wen L; Tou L; Wang H; Teng L
Front Surg; 2022; 9():986696. PubMed ID: 36439539
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological features of patients with Borrmann type IV gastric carcinoma.
Kim DY; Kim HR; Kim YJ; Kim S
ANZ J Surg; 2002 Oct; 72(10):739-42. PubMed ID: 12534387
[TBL] [Abstract][Full Text] [Related]
33. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor.
Taniguchi K; Yonemura Y; Nojima N; Hirono Y; Fushida S; Fujimura T; Miwa K; Endo Y; Yamamoto H; Watanabe H
Cancer; 1998 Jun; 82(11):2112-22. PubMed ID: 9610690
[TBL] [Abstract][Full Text] [Related]
34. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
35. Clinical and experimental role of ring finger protein 180 on lymph node metastasis and survival in gastric cancer.
Deng J; Liang H; Zhang R; Hou Y; Liu Y; Ying G; Pan Y; Hao X
Br J Surg; 2016 Mar; 103(4):407-16. PubMed ID: 26805552
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database.
Huang B; Sun Z; Wang Z; Lu C; Xing C; Zhao B; Xu H
BMC Cancer; 2013 Feb; 13():57. PubMed ID: 23379700
[TBL] [Abstract][Full Text] [Related]
37. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological and prognostic features of Borrmann type IV gastric cancer versus other Borrmann types: A unique role of signet ring cell carcinoma.
Liang C; Liang Y; Ou B; Yuan L; Yuan S
Saudi J Gastroenterol; 2023; 29(4):240-250. PubMed ID: 37470667
[TBL] [Abstract][Full Text] [Related]
39. PRRX1 promotes lymph node metastasis of gastric cancer by regulating epithelial-mesenchymal transition.
Yao J; Zhang Y; Xia Y; Zhu C; Wen X; Liu T; Da M
Medicine (Baltimore); 2021 Feb; 100(6):e24674. PubMed ID: 33578599
[TBL] [Abstract][Full Text] [Related]
40. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
